Ledger.Open graph →
SEC Form D · filed September 3, 2019

Sofregen Medical Inc

Offering
$8.1M
Sold
$8.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MEDFORD, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Kevin Pollack · Clearwater, FLExec · DirectorLaurence Curtis · TORONTO, Ontario, CanadaExec · DirectorAnh Hoang-Lindsay · Medford, MADirectorS. Douglas Sheldon · Medford, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗